Prism Johnson (500338) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
21 Aug, 2026Executive summary
Q2 FY26 consolidated revenue grew 12.6% YoY, reaching ₹1,826.75 crore, driven by strong performance in Prism Cement (+22.3% YoY) and Prism RMC (+12.3% YoY), while HRJ posted a modest 2.1% YoY increase.
EBITDA surged 224.9% YoY to ₹186 Crores, with margin expanding to 10.8%, led by improved realisations and lower operating costs, especially in Prism Cement.
Net profit turned positive at ₹3 Crores versus a loss of ₹91 Crores in Q2 FY25, reflecting operational improvements and cost efficiencies.
The results include the impact of exceptional items, notably a loss due to fire and gains from asset sales.
Financial highlights
Consolidated revenue reached ₹1,966 Crores, with Prism Cement contributing 44%, HRJ 33.9%, and Prism RMC 22.1%.
EBITDA margin improved to 10.8% from 3.7% YoY; Prism Cement EBITDA/tonne rose from ₹58 to ₹701.
Net debt increased to ₹1,067 Crores, with Net Debt/EBITDA at 1.8x and Net Debt/Equity at 0.6x as of September 30, 2025.
Net profit margin for the quarter was 0.09%, compared to -6.41% in the prior year quarter.
Earnings per share for the quarter stood at ₹0.06, up from a loss per share of ₹1.78 in the same quarter last year.
Outlook and guidance
Strong medium-term demand outlook for cement, supported by housing and infrastructure sectors, though competition is expected to intensify in Central India.
Plans to use proceeds from potential sale of non-core assets to further reduce debt.
Management highlighted the acquisition of additional stake in Samini Ceramics Limited, increasing shareholding from 50% to 90%, with further acquisition pending.
Latest events from Prism Johnson
- FY25 revenue reached ₹7,310 crore with strong cash flow and focus on sustainability and innovation.500338
Corporate presentation - Q1 FY25 revenue fell, EBITDA margin improved to 9.3%, but net loss reached ₹7.70 crore.500338
Q1 24/25 - Q2 FY25 saw a sharp YoY decline in revenue and margins, resulting in a significant net loss.500338
Q2 25/25 - Q3 FY25 revenue and net profit improved, but EBITDA and margins declined sharply.500338
Q3 24/25 - FY25 profit dropped on margin pressures and exceptional items, with debt reduction and asset sale.500338
Q4 24/25 - Revenue grew year-over-year, but profit declined amid margin pressures and arbitration.500338
Q1 25/26 - Profitability and margins rose sharply, aided by asset sales despite labor code expenses.500338
Q3 25/26 - Revenue and EBITDA rose, but net profit was hit by exceptional items and insurance sale pending.500338
Q4 25/26 - Record EBITDA growth and profit surge driven by asset sales and insurance divestment.500338
Q1 26/27